Vimarsana
Biggest News Aggregation in the World

Page 36 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

AMCON Distributing (NYSEAMERICAN:DIT) Stock Price Crosses Above Fifty Day Moving Average of $0.00 - Vimarsana News

AMCON Distributing (NYSEAMERICAN:DIT) Stock Price Crosses Above Fifty Day Moving Average of $0.00

Shares of AMCON Distributing (NYSEAMERICAN:DIT – Get Rating) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $195.83. AMCON Distributing shares last traded at $195.83, with a volume of 4,246 shares changing hands. Analyst Upgrades and Downgrades Separately, TheStreet […]

Maxim Group Initiates Coverage on Femasys (NASDAQ:FEMY) - Vimarsana News

Maxim Group Initiates Coverage on Femasys (NASDAQ:FEMY)

Investment analysts at Maxim Group assumed coverage on shares of Femasys (NASDAQ:FEMY – Get Rating) in a research report issued on Friday, Stock Target Advisor reports. The firm set a “buy” rating and a $5.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 284.62% from the stock’s previous […]

Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 19.5% in May - Vimarsana News

Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 19.5% in May

Cytosorbents Co. (NASDAQ:CTSO – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,940,000 shares, a decline of 19.5% from the May 15th total of 2,410,000 shares. Based on an average trading volume of 228,600 shares, the days-to-cover […]

Insider Buying: Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO Acquires 30,000 Shares of Stock - Vimarsana News

Insider Buying: Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO Acquires 30,000 Shares of Stock

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) CEO Thomas J. Schuetz bought 30,000 shares of the company’s stock in a transaction that occurred on Monday, June 13th. The shares were purchased at an average price of $2.29 per share, with a total value of $68,700.00. Following the transaction, the chief executive officer now directly owns […]

Angion Biomedica (NASDAQ:ANGN) Lowered to "Hold" at Zacks Investment Research - Vimarsana News

Angion Biomedica (NASDAQ:ANGN) Lowered to "Hold" at Zacks Investment Research

Angion Biomedica (NASDAQ:ANGN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Angion Biomedica Corp. is a late-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel […]